Regeneron Pharmaceuticals, Inc. vs The Sherwin-Williams Company

시간에 따른 시가총액 비교

Regeneron Pharmaceuticals, Inc.

$81.4B

순위 #194

The Sherwin-Williams Company

$81.8B

순위 #190

시간에 따른 시가총액

주요 순간

Regeneron Pharmaceuticals, Inc.이(가) 1995년까지 The Sherwin-Williams Company을(를) 추월했습니다
The Sherwin-Williams Company이(가) 1997년까지 Regeneron Pharmaceuticals, Inc.을(를) 추월했습니다
Regeneron Pharmaceuticals, Inc.이(가) 1999년까지 The Sherwin-Williams Company을(를) 추월했습니다
The Sherwin-Williams Company이(가) 2003년까지 Regeneron Pharmaceuticals, Inc.을(를) 추월했습니다
Regeneron Pharmaceuticals, Inc.이(가) 2012년까지 The Sherwin-Williams Company을(를) 추월했습니다
The Sherwin-Williams Company이(가) 2019년까지 Regeneron Pharmaceuticals, Inc.을(를) 추월했습니다
Regeneron Pharmaceuticals, Inc.이(가) 2022년까지 The Sherwin-Williams Company을(를) 추월했습니다
The Sherwin-Williams Company이(가) 2024년까지 Regeneron Pharmaceuticals, Inc.을(를) 추월했습니다

연도별 비교

연도	Regeneron Pharmaceuticals, Inc.	The Sherwin-Williams Company	선두
2026	$81.4B	$81.8B	The Sherwin-Williams Company
2025	$79.3B	$79.5B	The Sherwin-Williams Company
2024	$72.8B	$82.7B	The Sherwin-Williams Company
2023	$89.7B	$75.3B	Regeneron Pharmaceuticals, Inc.
2022	$73.7B	$56.7B	Regeneron Pharmaceuticals, Inc.
2021	$64.5B	$83.3B	The Sherwin-Williams Company
2020	$49.4B	$57.5B	The Sherwin-Williams Company
2019	$38.4B	$45.3B	The Sherwin-Williams Company
2018	$38.2B	$30.2B	Regeneron Pharmaceuticals, Inc.
2017	$38.4B	$31.2B	Regeneron Pharmaceuticals, Inc.
2016	$37.5B	$20.3B	Regeneron Pharmaceuticals, Inc.
2015	$55.5B	$19.3B	Regeneron Pharmaceuticals, Inc.
2014	$41.9B	$19.4B	Regeneron Pharmaceuticals, Inc.
2013	$28.1B	$13.4B	Regeneron Pharmaceuticals, Inc.
2012	$17.5B	$11.1B	Regeneron Pharmaceuticals, Inc.
2011	$5.7B	$6.4B	The Sherwin-Williams Company
2010	$3.4B	$5.9B	The Sherwin-Williams Company
2009	$2.5B	$4.2B	The Sherwin-Williams Company
2008	$1.9B	$4.0B	The Sherwin-Williams Company
2007	$2.5B	$3.8B	The Sherwin-Williams Company
2006	$2.1B	$4.1B	The Sherwin-Williams Company
2005	$1.6B	$2.9B	The Sherwin-Williams Company
2004	$941.1M	$2.7B	The Sherwin-Williams Company
2003	$1.5B	$2.1B	The Sherwin-Williams Company
2002	$1.9B	$1.7B	Regeneron Pharmaceuticals, Inc.
2001	$2.9B	$1.6B	Regeneron Pharmaceuticals, Inc.
2000	$3.6B	$1.5B	Regeneron Pharmaceuticals, Inc.
1999	$1.3B	$1.2B	Regeneron Pharmaceuticals, Inc.
1998	$753.6M	$1.6B	The Sherwin-Williams Company
1997	$874.9M	$1.5B	The Sherwin-Williams Company
1996	$1.6B	$1.5B	Regeneron Pharmaceuticals, Inc.
1995	$1.3B	$1.1B	Regeneron Pharmaceuticals, Inc.
1994	$306.5M	$850.4M	The Sherwin-Williams Company